IL10 and melanoma: Exosomes shed by melanoma cells after temozolomide treatment promote macrophage phenotype skewing towards the M2 phenotype and favor melanoma re-growth accompanied by an increase in Arginase 1 and IL10 gene expression levels by stromal cells and an increase in genes related to DNA repair, cell survival and stemness in tumor cells [70].